The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -36.31 Million | -61.75 Million | -32.68 Million | 508.23 Thousand | 3.61 Million | 5.64 Million |
| Net Income | -67.87 Million | 1.65 Million | -10.92 Million | -14.32 Million | -4.02 Million | 3.94 Million |
| Depreciation & Amortization | 5.87 Million | 4.41 Million | 3.34 Million | 3.17 Million | 2.94 Million | 1.1 Million |
| Deferred income taxes | -76 Thousand | 183 Thousand | -1.24 Million | -1.34 Million | 824.76 Thousand | 688.76 Thousand |
| Stock-based compensation | 17.81 Million | 27.68 Million | 24.53 Million | 151 Thousand | 94 Thousand | - |
| Change in working capital | 2.35 Million | -20.49 Million | -14.48 Million | 991.92 Thousand | 3.44 Million | -97.58 Thousand |
| Other non-cash items | 5.59 Million | -75.19 Million | -33.89 Million | 11.85 Million | 326.92 Thousand | 6.86 Million |
| Investing Cash Flow | 62.64 Million | -131.61 Million | -12.15 Million | -8.84 Million | -1.2 Million | 2.48 Million |
| Investments in PPE | -4.56 Million | -5.52 Million | -3.04 Million | -1.19 Million | -1.2 Million | -695.96 Thousand |
| Acquisitions | -4.45 Million | -8.57 Million | -9.1 Million | -150 Thousand | - | 3.18 Million |
| Investment purchases | -9.59 Million | -117.5 Million | - | - | - | - |
| Sales/Maturities of investments | 81.25 Million | 126.08 Million | - | - | - | - |
| Other Investing Activities | 71.66 Million | -126.08 Million | -200 Thousand | -7.5 Million | - | - |
| Financing Cash Flow | -6.84 Million | 92.2 Million | 154.01 Million | 11.88 Million | -1814.00 | -8.2 Million |
| Debt repayment | -101 Thousand | -58 Thousand | -7.25 Million | -12.18 Million | -1814.00 | - |
| Dividends payments | - | - | - | - | - | -8.2 Million |
| Common Stock Repurchased | -1.01 Million | -9 Million | - | - | - | - |
| Common Stock Issuance | 126 Thousand | 858 Thousand | 20 Million | -293 Thousand | 25 Thousand | - |
| Other Financing Activities | -5.85 Million | 100.4 Million | 141.26 Million | -293 Thousand | -25 Thousand | - |
| Accounts receivables | -4.49 Million | -20.28 Million | -2.19 Million | -6.76 Million | -4.32 Million | -1.38 Million |
| Accounts payables | 5.05 Million | -6.18 Million | 2.91 Million | 3.75 Million | 5.52 Million | 6.07 Million |
| Inventory | -4.38 Million | -1.73 Million | -1.84 Million | -465.24 Thousand | -1.13 Million | -296.76 Thousand |
| Other working capital | 6.18 Million | 7.7 Million | -13.36 Million | 4.46 Million | 3.38 Million | -4.48 Million |
| Cash at beginning of period | 14.01 Million | 115.17 Million | 5.99 Million | 2.44 Million | 37.31 Thousand | 52 Thousand |
| Cash at end of period | 33.48 Million | 14.01 Million | 115.17 Million | 5.99 Million | 2.44 Million | 37.31 Thousand |
| Capital Expenditure | -4.56 Million | -5.52 Million | -3.04 Million | -1.19 Million | -1.2 Million | -695.96 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 55.21 Thousand |
| Net cash flow / Change in cash | 19.47 Million | -101.16 Million | 109.17 Million | 3.55 Million | 2.4 Million | -14.68 Thousand |
| Free Cash Flow | -40.88 Million | -67.28 Million | -35.72 Million | -685.88 Thousand | 2.41 Million | 4.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.67 Million | -16.27 Million | -15.31 Million | -67.87 Million | -17.41 Million | -16.89 Million |
| Depreciation & Amortization | 1.51 Million | 1.48 Million | 1.57 Million | 5.87 Million | 1.69 Million | 1.32 Million |
| Deferred income taxes | 99 Thousand | - | -126 Thousand | -76 Thousand | 80 Thousand | -4000.00 |
| Stock-based compensation | 3.38 Million | 4.08 Million | 4.07 Million | 17.81 Million | 4.65 Million | 4.1 Million |
| Change in working capital | -3.4 Million | -2.73 Million | 6.44 Million | 2.35 Million | -1.11 Million | 1.8 Million |
| Other non-cash items | 2.4 Million | 12.34 Million | -555 Thousand | 5.59 Million | 3.78 Million | 1 Million |
| Investing Cash Flow | 18.17 Million | 19.38 Million | 11.62 Million | 62.64 Million | 7.7 Million | 24.9 Million |
| Investments in PPE | -1.82 Million | -610 Thousand | -861 Thousand | -4.56 Million | -930 Thousand | -937 Thousand |
| Acquisitions | - | - | -156 Thousand | -4.45 Million | -8.63 Million | -4.3 Million |
| Investment purchases | - | - | 88 Thousand | -9.59 Million | 64 Thousand | 12 Thousand |
| Sales/Maturities of investments | 20 Million | 19.99 Million | 12.55 Million | 81.25 Million | 8.57 Million | 30.12 Million |
| Other Investing Activities | 20 Million | 19.99 Million | 12.64 Million | 71.66 Million | 8.63 Million | 30.14 Million |
| Financing Cash Flow | -2.14 Million | -938 Thousand | -1.78 Million | -6.84 Million | -756 Thousand | -2.6 Million |
| Debt repayment | -9000.00 | -9000.00 | -10 Thousand | -101 Thousand | -10 Thousand | -63 Thousand |
| Dividends payments | - | - | -13 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | -1.01 Million | -125 Thousand | -894 Thousand |
| Common Stock Issuance | 2000.00 | 73 Thousand | 113 Thousand | 126 Thousand | 13 Thousand | - |
| Other Financing Activities | -2.14 Million | -1 Million | -1.88 Million | -5.85 Million | -621 Thousand | -1.64 Million |
| Accounts receivables | 4.76 Million | -16.21 Million | 4 Million | -4.49 Million | -2.08 Million | -435 Thousand |
| Accounts payables | -5.45 Million | 6.35 Million | 1.09 Million | 5.05 Million | 210 Thousand | 1.17 Million |
| Inventory | 232 Thousand | 2.12 Million | -1.47 Million | -4.38 Million | -6000.00 | -1.91 Million |
| Other working capital | -2.94 Million | 5 Million | 2.81 Million | 6.18 Million | 766 Thousand | 2.97 Million |
| Cash at beginning of period | 36.05 Million | 33.48 Million | 27.53 Million | 14.01 Million | 28.89 Million | 15.25 Million |
| Cash at end of period | 36.42 Million | 36.05 Million | 33.48 Million | 33.48 Million | 27.53 Million | 28.89 Million |
| Capital Expenditure | -1.82 Million | -610 Thousand | -861 Thousand | -4.56 Million | -930 Thousand | -937 Thousand |
| Effect of forex changes on cash | - | - | 11 Thousand | - | -9.57 Million | -25 Million |
| Net cash flow / Change in cash | 369 Thousand | 2.56 Million | 5.95 Million | 19.47 Million | -1.35 Million | 13.64 Million |
| Free Cash Flow | -17.48 Million | -16.49 Million | -4.75 Million | -40.88 Million | -9.24 Million | -9.59 Million |
PMV
MTWO
VMUK
SEQI
7363
1905